These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30101657)

  • 1. What is holding up the Unified Patent Court?
    Cohen L; Johnson A
    Pharm Pat Anal; 2018 Sep; 7(5):187-192. PubMed ID: 30101657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Unified Patent Court: where are we and what should you be doing?
    Freeland R
    Pharm Pat Anal; 2017 Nov; 6(6):247-249. PubMed ID: 29022845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. At a glance: the European patent with unitary effect.
    Höpfner S
    Pharm Pat Anal; 2016 Sep; 5(5):295-300. PubMed ID: 27531460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent injunctions in Europe: the return of the pan-European injunction--or how can you get a decision from one court effective in more than one country?
    Freeland R
    Pharm Pat Anal; 2015; 4(6):405-7. PubMed ID: 26580987
    [No Abstract]   [Full Text] [Related]  

  • 5. Patent litigation in India continues to throw up new challenges.
    Reddy Thikkavarapu P
    Pharm Pat Anal; 2016 Jul; 5(4):211-6. PubMed ID: 27348790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Unitary Patent and UPC - Implications for the pharmaceutical sector.
    Mummery Z
    Drug Discov Today; 2022 Dec; 27(12):103388. PubMed ID: 36195203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will changes to patent infringements attract drug research in the UK?
    Snodin M
    Expert Opin Ther Pat; 2015; 25(9):949-51. PubMed ID: 25813963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Better protection for patentees: preliminary injunctions in the EU for pharmaceutical patent matters.
    von Falck A; Gundt M
    Pharm Pat Anal; 2013 May; 2(3):291-3. PubMed ID: 24237054
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug patents and other ways to protect pharmaceutical research].
    Ohana P; Tardieu S; Blin O; Tassy S; Sambuc R
    Therapie; 2004; 59(2):253-7. PubMed ID: 15359623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compulsory licenses as a defense in pharmaceutical and biotech patent litigation.
    von Falck A
    Pharm Pat Anal; 2016 Sep; 5(6):351-353. PubMed ID: 27805479
    [No Abstract]   [Full Text] [Related]  

  • 11. An overview of pharmaceutical patent litigation in China.
    Carver T
    Pharm Pat Anal; 2016; 5(2):75-7. PubMed ID: 26891143
    [No Abstract]   [Full Text] [Related]  

  • 12. Legitimate patent extension or patent system abuse?
    Atkinson JD; Moodie RS
    Pharm Pat Anal; 2013 May; 2(3):317-24. PubMed ID: 24237059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent protection in Europe of pharmaceuticals found to have a further medical indication.
    Cockbain J
    Pharm Pat Anal; 2012 Mar; 1(1):17-8. PubMed ID: 24236708
    [No Abstract]   [Full Text] [Related]  

  • 14. EU court gets tough on patent extensions for combo products.
    Waters H
    Nat Med; 2012 Jan; 18(1):4. PubMed ID: 22227647
    [No Abstract]   [Full Text] [Related]  

  • 15. Preliminary injunctions in generic and branded patent litigation.
    Cohen S; England P
    Expert Opin Ther Pat; 2013 Sep; 23(9):1083-6. PubMed ID: 23855903
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmaceutical patent law: the Canadian perspective.
    Aumand L; Norman J
    Pharm Pat Anal; 2016 Jul; 5(4):271-9. PubMed ID: 27346187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on Brazil's pharma patent landscape.
    Gosain R
    Pharm Pat Anal; 2016 Sep; 5(6):385-390. PubMed ID: 27804784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obtaining, challenging and enforcing pharmaceutical patents under the America Invents Act.
    Genieser LH; McCann CE
    Pharm Pat Anal; 2012 Sep; 1(4):415-26. PubMed ID: 24236880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transatlantic divide: how divisional and continuing patent application filing practice differs between the USA and Europe.
    Nytko-Lutz E; Crease D
    Pharm Pat Anal; 2012 Jul; 1(3):245-8. PubMed ID: 24236836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teva Pharmaceuticals v. Sandoz: availability of generic glatiramer acetate and the impact to patent litigation claim construction.
    Fogel LE; Ray CJ
    Expert Opin Ther Pat; 2015 Jan; 25(1):1-4. PubMed ID: 25363310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.